Digital PNG artwork · delivered by email | Secure checkout · no physical shipping

What Are Retinoids?

Retinoids are a class of vitamin A-derived compounds that act through retinoic acid receptors; this page summarises the research literature, including where findings are animal-only or in vitro.

Retinoids are a class of natural and synthetic compounds structurally or functionally related to vitamin A (retinol). In the research literature they are grouped together because they share a common signalling route rather than a single structure: the class spans retinol, retinal, retinoic acid and a large set of synthetic analogues. The evidence block for this page does not supply a sequence, molecular formula or molecular weight for any individual retinoid, so no such identifiers are given here. Where the literature names them, retinoids appear alongside corticosteroids, vitamin D analogs and biologics as pharmacological treatment options for psoriasis [3][4], and alongside peptides, antioxidants and exosome-based formulations as topical agents in skin-aging research [1].

The work in this area centres on retinoic acid receptor signalling — the pathway through which retinoids are understood to act on skin tissue, and the reason the class is treated as a single research subject rather than a set of unrelated molecules.

Research Studies

Retinoids and topical skin-aging approaches

A review of integrative approaches to skin longevity examined the validity of combining topical treatments — retinoids among them — with internal nutraceuticals. The review frames skin aging as the product of both intrinsic biological decline and extrinsic exposures collectively described as the skin exposome, including ultraviolet radiation, air pollution, psychosocial stress, fatigue, sleep disruption and suboptimal lifestyle behaviours. In that framing, the skin is treated both as a visible marker of whole-body aging and as a target for longevity strategies [1].

Retinoids and psoriasis treatment options

In psoriasis research, retinoids are listed among the main pharmacological options for most patients, together with corticosteroids, vitamin D analogs and biologics. The same source notes that side effects and high cost have barred many ordinary psoriasis patients from benefiting from these treatments [3][4]. Psoriasis is described as an inflammatory skin disease with an overall prevalence of 2% to 3% in the general population, with plaque psoriasis the most common type, presenting as red, well demarcated, silvery plaques mainly localised to the umbilical and lumbosacral area as well as the elbows, knees and scalp [3][4].

Retinoids and pregnancy skin-care guidance

A consensus document on pregnancy skin care synthesised expert recommendations intended to support maternal skin health while prioritising fetal safety. The guidance emphasises gentle cleansing, adequate hydration, mineral-based sun protection, and dermatologically safe ingredients such as vitamin C, hyaluronic acid, niacinamide and azelaic acid. Within the same consensus, retinoids are named among the substances to be avoided during pregnancy, alongside high-dose salicylic acid and certain chemical sunscreens [2]. This is a clinical guidance statement about a defined population — pregnant individuals — and is reported here as such.

Retinoids as a comparator in Chinese medicine psoriasis trials

Two registered trials of Chinese medicine formulas for psoriasis position retinoids as part of the existing pharmacological landscape against which new approaches are considered. One evaluates a Shuiniujiao Dihuang decoction with variation [3]; the other evaluates an inflammatory skin disease formula [4]. In both, the stated rationale is that side effects and cost limit access to the current mainstays — retinoids, corticosteroids, vitamin D analogs and biologics — for many patients [3][4]. These records describe trial design and background rather than reporting retinoid outcomes.

Retinoids and acne-induced hyperpigmentation

A review of practical therapeutic strategies for acne-induced hyperpigmentation addresses post-inflammatory hyperpigmentation and post-inflammatory erythema as common sequelae of acne, particularly affecting individuals with skin of colour. It reports that up to 85% of patients with Fitzpatrick phototypes IV–VI develop post-inflammatory hyperpigmentation following inflammatory acne lesions [5]. This source is included as background on the clinical context in which topical agents are studied; it is not built around retinoid findings.

Where the evidence sits

The material available for this page is clinical review, consensus guidance and trial-registry documentation. It does not include animal-only or in vitro retinoid studies, and no such findings are reported here. The table below summarises how retinoids are positioned across the sources.

SourceContextHow retinoids are positionedPopulation or setting
[1]Skin aging and longevityNamed among topical treatments in an integrative approachReview of topical and internal strategies
[2]Pregnancy skin careNamed among substances to avoidPregnant individuals
[3]PsoriasisNamed among main pharmacological treatmentsPsoriasis patients; general population prevalence 2–3%
[4]PsoriasisNamed among main pharmacological treatmentsPsoriasis patients; general population prevalence 2–3%
[5]Acne-induced hyperpigmentationBackground context onlyPatients with Fitzpatrick phototypes IV–VI

If you are reading this for personal health reasons

The compounds described on this page are sold for laboratory research use only. We do not provide dosing information or medical guidance of any kind. Anyone considering a retinoid for their own use should speak to a licensed clinician.

Sources

WhatsApp